Pancreatic cancer stem cells and inflammation: milestones achieved and challenges ahead
- 3 November 2023
- book chapter
- Published by Elsevier
- p. 207-226
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF TreatmentPLOS ONE, 2012
- CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck CancerPLOS ONE, 2011
- Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancerBMC Cancer, 2011
- ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic AdenocarcinomaPLOS ONE, 2011
- The Wnt/β-catenin pathway regulates growth and maintenance of colonospheresMolecular Cancer, 2010
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic AdenocarcinomaJNCI: Journal of the National Cancer Institute, 2010
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancerBritish Journal of Cancer, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003